rifampin has been researched along with Mucormycosis* in 3 studies
2 review(s) available for rifampin and Mucormycosis
| Article | Year |
|---|---|
[Mucormycosis. Clinical cases and update].
Mucormycosis is an emerging mycotic infection with high mortality. We described the clinical presentation, evolution and treatment of 5 patients with diagnosis of mucormycosis.. La mucormicosis es una micosis emergente, de elevada mortalidad. El objetivo del estudio es presentar las características clínicas y evolución de los casos asistidos en el Sanatorio Allende, de la Ciudad de Córdoba República Argentina y hacer una actualización bibliografíca. Se presentan 5 pacientes con mucormicosis con diferentes formas clínicas de presentación. El diagnóstico clínico se confirmó por histopatología y/o cultivo de los tejidos. Concluimos que en la actualidad la sospecha clínica basada en la forma de presentación y los factores de riesgo siguen siendo claves para establecer la sospecha clínica y realizar el diagnóstico temprano. En cuanto al tratamiento se basa fundamentalmente en el desbridamiento quirúrgico para eliminación del tejido necrótico y Anfotericina liposomal como antifúngico de elección. El posaconazol nuevo triazol tendría un rol importante en la consolidación del tratamiento una vez que el paciente logra la estabilización clínica o como tratamiento de rescate. Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Fatal Outcome; Female; Humans; Male; Middle Aged; Mucormycosis; Rifampin; Risk Factors; Triazoles; Young Adult | 2014 |
Successful treatment of sinusitis caused by Cunninghamella bertholletiae.
Seventeen cases of infections due to Cunninghamella species have been reported worldwide in humans, and there have been only three survivors. We report a case of paranasal sinusitis due to Cunninghamella bertholletiae in an elderly patient who had diabetes mellitus and myelodysplasia. After receiving 7 weeks of therapy with deoxycholate amphotericin B (44 mg/kg or a total of 3 g) and rifampin, the patient was cured and did not have to undergo radical surgery. Topics: Aged; Amphotericin B; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Ethmoid Sinusitis; Humans; Male; Maxillary Sinusitis; Mucorales; Mucormycosis; Myelodysplastic Syndromes; Paranasal Sinuses; Rifampin; Tomography, X-Ray Computed | 1994 |
1 other study(ies) available for rifampin and Mucormycosis
| Article | Year |
|---|---|
Pulmonary mucormycosis presenting with Horner's syndrome. Report of a medical cure.
A patient with pulmonary mucormycosis caused by Rhizopus oryzae was treated with a total dose of intravenous amphotericin B 2060 mg which resulted in medical cure. This is the first reported medical cure in the RSA of pulmonary mucormycosis. Mucormycosis with brachial plexus involvement and Horner's syndrome has not been previously reported. Topics: Amphotericin B; Drug Therapy, Combination; Horner Syndrome; Humans; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Rhizopus; Rifampin | 1986 |